Amundi - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 243 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Amundi ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$60,025
-20.8%
4,8020.0%0.00%
Q2 2023$75,776
+6.5%
4,8020.0%0.00%
Q1 2023$71,118
-21.9%
4,802
-44.6%
0.00%
Q4 2022$91,038
-14.9%
8,662
-25.9%
0.00%
Q3 2022$107,000
+10.3%
11,6850.0%0.00%
Q2 2022$97,00011,6850.00%
Other shareholders
NEOGENOMICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,046,639$12,8748.15%
Greenhouse Funds LLLP 3,981,003$48,966,3373.62%
First Light Asset Management, LLC 3,028,913$37,255,6303.54%
PERKINS CAPITAL MANAGEMENT INC 193,950$2,3862.36%
EMERALD MUTUAL FUND ADVISERS TRUST 1,557,895$19,162,1091.16%
EMERALD ADVISERS, LLC 1,927,074$23,703,0051.15%
Bullseye Asset Management LLC 163,792$2,0151.12%
FORMULA GROWTH LTD 208,885$2,569,2860.88%
OAK FAMILY ADVISORS, LLC 96,737$1,189,8650.56%
Parkman Healthcare Partners LLC 245,812$3,023,4880.55%
View complete list of NEOGENOMICS INC shareholders